Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gian Franco Placidi is active.

Publication


Featured researches published by Gian Franco Placidi.


Journal of Endocrinological Investigation | 2005

Eating disorders in patients with Type 1 diabetes: A meta-analysis

Edoardo Mannucci; Francesco Rotella; Valdo Ricca; S. Moretti; Gian Franco Placidi; Carlo Maria Rotella

A meta-analysis of controlled studies on prevalence of eating disorders in Type 1 diabetes was performed in order to assess differences between diabetic and non-diabetic female subjects. All controlled studies using the Diagnostic and Statistical Manual of Mental Disorders Third Edition Revised (DSM III-R) or the DSM Fourth Edition (DSM IV) criteria for interview-based diagnosis were included in the analysis. The total sample was composed of 748 and 1587 female subjects with and without diabetes, respectively. The prevalence of anorexia nervosa (AN) in Type 1 diabetic subjects was not significantly different from that of controls (0.27 vs 0.06%), while that of bulimia nervosa and of the two conditions combined was significantly higher in diabetic patients (1.73 vs 0.69%, and 2.00 vs 0.75%, respectively; both p<0.05). Type 1 diabetes is associated with a higher prevalence of bulimia nervosa in females.


International Journal of Obesity | 2002

Eating behavior in obese patients with and without type 2 diabetes mellitus

Edoardo Mannucci; F. Tesi; Valdo Ricca; E Pierazzuoli; Elisabetta Barciulli; S. Moretti; M. Di Bernardo; R. Travaglini; S Carrara; T. Zucchi; Gian Franco Placidi; Carlo Maria Rotella

Objective: Aim of this study was the assessment of the prevalence of eating disorders, and of eating disorder symptoms, in obese patients with type 2 diabetes, compared to non-diabetic subjects.Design: Three samples of individuals were studied: a series of 156 (76 male, 80 female) overweight and obese type 2 diabetic patients, aged 30–65 y, with a body mass index (BMI)>28 kg/m2 (DM); a series of 192 (20 male, 172 female) obese (BMI>30 kg/m2) non-diabetic patients aged 30–65 y seeking treatment for weight loss (OC); and a non-clinical sample of 48 (22 male, 26 female) obese (BMI>30 kg/m2) subjects aged 30–65 y selected from the lists of two general practices (OP). Eating behavior was assessed using the Eating Disorder Examination (EDE 12.0D).Results: The prevalence of Binge Eating Disorder was lower than 5% in all the three samples. Median EDE scores in females were significantly higher in OC (3.0) and OP (3.4) than in DM (1.7), while diabetic patients showed higher scores on Restraint than both non-diabetic samples. Among diabetic patients, a significant correlation of EDE scores with HbA1c was observed.Conclusions: Type 2 diabetes is unlikely to induce relevant eating disturbances in obese patients, apart from an increase in restraint. Abnormalities of eating attitudes and behavior are associated with an impairment of metabolic control.


Psychiatry Research-neuroimaging | 1990

Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder

Luigi Bartalena; Laura Pellegrini; Marisa Meschi; L Antonangeli; Fausto Bogazzi; Liliana Dell'Osso; Aldo Pinchera; Gian Franco Placidi

The problem of whether rapid-cycling (RC) bipolar disorder is more frequently associated than non-rapid-cycling (NRC) bipolar disorders with thyroid dysfunction was investigated in two groups of 11 women matched for age and therapy. Seven patients in each group were under chronic lithium therapy. Both RC and NRC patients, as compared to euthyroid controls, showed a reduction in mean total and free thyroid hormone concentrations, subnormal values of free thyroxine being found in four RC and three NRC patients. No patient had supranormal baseline thyroid stimulating hormone (TSH) values, but an exaggerated TSH response to thyrotropin releasing hormone was found in three RC and two NRC patients: all these patients had been receiving lithium therapy for more than one year. No differences in the prevalence of goiter and thyroid-directed autoantibodies were observed in the two groups. These data confirm that bipolar disorder, especially during treatment with lithium, is associated with at least subclinical hypothyroidism, and suggest that RC patients do not differ from NRC patients in the prevalence of spontaneous or lithium-induced thyroid hypofunction. Lithium-induced hypothyroidism is likely to be related to the length of treatment.


Neuroscience Letters | 2004

Psychopathological traits and 5-HT2A receptor promoter polymorphism (−1438 G/A) in patients suffering from Anorexia Nervosa and Bulimia Nervosa

Valdo Ricca; Benedetta Nacmias; Maura Boldrini; Elena Cellini; Milena Di Bernardo; Claudia Ravaldi; Andrea Tedde; Silvia Bagnoli; Gian Franco Placidi; Carlo Maria Rotella; Sandro Sorbi

Various studies have evaluated the possible role of the -1438G/A polymorphism within the 5-HT2A receptor gene in the susceptibility to Eating Disorders (EDs). One hundred and forty-eight ED patients (EDp) and 89 control subjects were interviewed by means of the Eating Disorder Examination (EDE) and analyzed for distribution of the -1438G/A polymorphism. Patients with the AA genotype suffering from Anorexia Nervosa and Bulimia Nervosa showed higher Weight and Shape Concern (P = 0.003 and P = 0.010, respectively) scores and greater overall severity of the ED psychopathology (EDE total score) (P = 0.012). The obtained preliminary data suggest the use of dimensional psychopathological measures in ED genetic studies.


Journal of Psychoactive Drugs | 2004

Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status

Icro Maremmani; Antonio Lazzeri; Matteo Pacini; Mercedes Lovrecic; Gian Franco Placidi; Giulio Perugi

Abstract The prevalence and the clinical meaning of cannabis use in patients with chronic psychosis has not been systematically explored. The authors have compared the diagnostic and symptomatological characteristics of 111 male patients affected by chronic psychosis with and without past or current use of cannabis. Sixty-six patients were still using or had used cannabis; in all cases the use preceded the onset of psychotic symptoms. Forty-three patients were cannabis-positive on urinary screening at the moment of hospitalization and 23 were currently cannabis-free but reported the use of cannabis in the past. Forty-five patients were negative on urinary screening and reported no past history of cannabis use. In evaluating the psychopathological features, the Brief Psychiatric Rating Scale (BPRS) and the Overt Aggression Rating Scale (AORS) were used. The three groups showed similar demographic data, except for age, which was lower in current cannabis users than in nonusers; no differences were found between current and past users. As regards diagnostic features, “mood cluster” was significantly better represented in cannabis users and “schizophrenic cluster” in nonusers; bipolar spectrum disorders were more frequently reported than unipolar ones. When past and current users were grouped together, only blunted affect score was significantly higher in nonusers than in users, while clastic violence showed higher scores in users. These data indicate that chronic psychosis, whether associated with past or with current use of cannabis, is frequently associated with bipolar spectrum disorders and tends to display less blunted affect and more clastic behavior.


The International Journal of Neuropsychopharmacology | 2003

Paroxetine efficacy in stuttering treatment

Maura Boldrini; Michele Rossi; Gian Franco Placidi

Stuttering is usually developmental, with onset at 4 to 5 years of age, and sometime may have a genetic component; among the possible cause of stuttering, response to conflicts, fears, neurosis, organic models, and learning models have been proposed (Andrews et al., 1983). Stuttering can be neurogenic (or acquired) as a result of stroke, head injury and degenerative or metabolic brain damage (Grant et al., 1999).


Eating and Weight Disorders-studies on Anorexia Bulimia and Obesity | 2004

Affective temperament in the eating disorders.

Carla E. Ramacciotti; R. A. Paoli; Antonio Ciapparelli; G. Marcacci; Gian Franco Placidi; L. Dell’Osso; Paul E. Garfinkel

Background: In this study, we investigate the affective temperamental characteristics in a sample of ED (eating disorder) patients. Methods: 49 ED patients diagnosed by the SCID (Structured Clinical Interview for DSM-IV), were divided into two groups on the basis of the presence or absence of Binge Eating (restricting-anorexia nervosa [R-AN]= 16; Binge Eaters= 33). All patients were administered the TEMPS-I (Temperament Evaluation Memphis Pisa Semistructured — Interview), to assess affective temperament. A third group of controls (N= 1010), derived from a study with the TEMPS-I on normal subjects, was included for comparison. Results: A full affective temperament was not found in patients of the restricting group. By contrast 24% of the binge eating group had a full affective temperament of one of three types. Comparing the three temperaments for the three groups, only cyclothymic temperament proved to be significant, with higher levels in the binge eating group (p<0.01). Conclusions: In this study, people with R-AN do not show a full affective temperament. However, people with binge eating, had depressive and hyperthymic temperament, and displayed higher level of cyclothymic temperament than the normal population. The findings of this study add to a growing literature on temperament in people with ED; particularly, they add to the view that may be various paths leading to R-AN, and these may differ from those of binge eating.


Modern problems of pharmacopsychiatry | 1989

Ateroid in the Treatment of Dementia: Results of a Clinical Trial

L Conti; Gian Franco Placidi; Giovanni B. Cassano


Archive | 1993

Recurrent Mood Disorders

Gian Franco Placidi; Liliana Dell’Osso; Giuseppe Nisticò; Hagop S. Akiskal


Neuropsychobiology | 1987

A 3H-flunitrazepam binding inhibitor is present in psychiatric patients' sera.

Donatella Marazziti; Pietro Pietrini; Claudia Martini; Gino Giannaccini; Giulio Perugi; Gian Franco Placidi; Giovanni B. Cassano; Antonio Lucacchini

Collaboration


Dive into the Gian Franco Placidi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Valdo Ricca

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Moretti

University of Florence

View shared research outputs
Researchain Logo
Decentralizing Knowledge